[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Supportive Care Medicine-North America Market Status and Trend Report 2013-2023

February 2018 | 142 pages | ID: C03BEBAA787MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Cancer Supportive Care Medicine-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Supportive Care Medicine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole North America and Regional Market Size of Cancer Supportive Care Medicine 2013-2017, and development forecast 2018-2023
Main market players of Cancer Supportive Care Medicine in North America, with company and product introduction, position in the Cancer Supportive Care Medicine market
Market status and development trend of Cancer Supportive Care Medicine by types and applications
Cost and profit status of Cancer Supportive Care Medicine, and marketing status
Market growth drivers and challenges

The report segments the North America Cancer Supportive Care Medicine market as:

North America Cancer Supportive Care Medicine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

United States
Canada
Mexico

North America Cancer Supportive Care Medicine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Antiemetic Drugs
Erythropoietin-Stimulating Agents
Granulocyte-Stimulating Agents
Analgesics
Others

North America Cancer Supportive Care Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Chemotherapy-Induced Anemia
CINV
Bone Metastasis
Cancer Pain
Other

North America Cancer Supportive Care Medicine Market: Players Segment Analysis (Company and Product introduction, Cancer Supportive Care Medicine Sales Volume, Revenue, Price and Gross Margin):

Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Heron Therapeutics
Kyowa Hakko Kirin
Novartis
TESARO
Teva Pharmaceutical Industries

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CANCER SUPPORTIVE CARE MEDICINE

1.1 Definition of Cancer Supportive Care Medicine in This Report
1.2 Commercial Types of Cancer Supportive Care Medicine
  1.2.1 Antiemetic Drugs
  1.2.2 Erythropoietin-Stimulating Agents
  1.2.3 Granulocyte-Stimulating Agents
  1.2.4 Analgesics
  1.2.5 Others
1.3 Downstream Application of Cancer Supportive Care Medicine
  1.3.1 Chemotherapy-Induced Anemia
  1.3.2 CINV
  1.3.3 Bone Metastasis
  1.3.4 Cancer Pain
  1.3.5 Other
1.4 Development History of Cancer Supportive Care Medicine
1.5 Market Status and Trend of Cancer Supportive Care Medicine 2013-2023
  1.5.1 North America Cancer Supportive Care Medicine Market Status and Trend 2013-2023
  1.5.2 Regional Cancer Supportive Care Medicine Market Status and Trend 2013-2023

CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Cancer Supportive Care Medicine in North America 2013-2017
2.2 Consumption Market of Cancer Supportive Care Medicine in North America by Regions
  2.2.1 Consumption Volume of Cancer Supportive Care Medicine in North America by Regions
  2.2.2 Revenue of Cancer Supportive Care Medicine in North America by Regions
2.3 Market Analysis of Cancer Supportive Care Medicine in North America by Regions
  2.3.1 Market Analysis of Cancer Supportive Care Medicine in United States 2013-2017
  2.3.2 Market Analysis of Cancer Supportive Care Medicine in Canada 2013-2017
  2.3.3 Market Analysis of Cancer Supportive Care Medicine in Mexico 2013-2017
2.4 Market Development Forecast of Cancer Supportive Care Medicine in North America 2018-2023
  2.4.1 Market Development Forecast of Cancer Supportive Care Medicine in North America 2018-2023
  2.4.2 Market Development Forecast of Cancer Supportive Care Medicine by Regions 2018-2023

CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole North America Market Status by Types
  3.1.1 Consumption Volume of Cancer Supportive Care Medicine in North America by Types
  3.1.2 Revenue of Cancer Supportive Care Medicine in North America by Types
3.2 North America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in United States
  3.2.2 Market Status by Types in Canada
  3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Cancer Supportive Care Medicine in North America by Types

CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Cancer Supportive Care Medicine in North America by Downstream Industry
4.2 Demand Volume of Cancer Supportive Care Medicine by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Cancer Supportive Care Medicine by Downstream Industry in United States
  4.2.2 Demand Volume of Cancer Supportive Care Medicine by Downstream Industry in Canada
  4.2.3 Demand Volume of Cancer Supportive Care Medicine by Downstream Industry in Mexico
4.3 Market Forecast of Cancer Supportive Care Medicine in North America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CANCER SUPPORTIVE CARE MEDICINE

5.1 North America Economy Situation and Trend Overview
5.2 Cancer Supportive Care Medicine Downstream Industry Situation and Trend Overview

CHAPTER 6 CANCER SUPPORTIVE CARE MEDICINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA

6.1 Sales Volume of Cancer Supportive Care Medicine in North America by Major Players
6.2 Revenue of Cancer Supportive Care Medicine in North America by Major Players
6.3 Basic Information of Cancer Supportive Care Medicine by Major Players
  6.3.1 Headquarters Location and Established Time of Cancer Supportive Care Medicine Major Players
  6.3.2 Employees and Revenue Level of Cancer Supportive Care Medicine Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 CANCER SUPPORTIVE CARE MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Amgen
  7.1.1 Company profile
  7.1.2 Representative Cancer Supportive Care Medicine Product
  7.1.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Amgen
7.2 Helsinn Healthcare
  7.2.1 Company profile
  7.2.2 Representative Cancer Supportive Care Medicine Product
  7.2.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Helsinn Healthcare
7.3 Johnson &Johnson
  7.3.1 Company profile
  7.3.2 Representative Cancer Supportive Care Medicine Product
  7.3.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Johnson &Johnson
7.4 Merck
  7.4.1 Company profile
  7.4.2 Representative Cancer Supportive Care Medicine Product
  7.4.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Merck
7.5 F. Hoffmann-La Roche
  7.5.1 Company profile
  7.5.2 Representative Cancer Supportive Care Medicine Product
  7.5.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.6 GlaxoSmithKline
  7.6.1 Company profile
  7.6.2 Representative Cancer Supportive Care Medicine Product
  7.6.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.7 Heron Therapeutics
  7.7.1 Company profile
  7.7.2 Representative Cancer Supportive Care Medicine Product
  7.7.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Heron Therapeutics
7.8 Kyowa Hakko Kirin
  7.8.1 Company profile
  7.8.2 Representative Cancer Supportive Care Medicine Product
  7.8.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Kyowa Hakko Kirin
7.9 Novartis
  7.9.1 Company profile
  7.9.2 Representative Cancer Supportive Care Medicine Product
  7.9.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Novartis
7.10 TESARO
  7.10.1 Company profile
  7.10.2 Representative Cancer Supportive Care Medicine Product
  7.10.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of TESARO
7.11 Teva Pharmaceutical Industries
  7.11.1 Company profile
  7.11.2 Representative Cancer Supportive Care Medicine Product
  7.11.3 Cancer Supportive Care Medicine Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CANCER SUPPORTIVE CARE MEDICINE

8.1 Industry Chain of Cancer Supportive Care Medicine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CANCER SUPPORTIVE CARE MEDICINE

9.1 Cost Structure Analysis of Cancer Supportive Care Medicine
9.2 Raw Materials Cost Analysis of Cancer Supportive Care Medicine
9.3 Labor Cost Analysis of Cancer Supportive Care Medicine
9.4 Manufacturing Expenses Analysis of Cancer Supportive Care Medicine

CHAPTER 10 MARKETING STATUS ANALYSIS OF CANCER SUPPORTIVE CARE MEDICINE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications